跳至主要内容
临床试验/DRKS00023620
DRKS00023620招募中不适用

A Post-Market Clinical Follow-up Study of the Auto Tissue Berlin Equine Matrix Patch™:The All-Patch Study - ATB-1

Auto Tissue Berlin GmbH0 个研究点目标入组 100 人开始时间: 2021年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • 1. Diagnosed with cardiac or vascular disease for which surgical repair involving a tissue patch is indicated.
  • 2. Written consent of the patient or the legal guardian.

排除标准

  • 1. Patients in whom the treating physician or surgeon believes that the risks of using a xenograft for repair of congenital or acquired cardiac or vascular tissue defects outweigh the benefits.
  • 2. Patient is participating in an investigational drug or device study that has not reached the primary endpoint or that interferes with the current study endpoints.
  • 3. Any condition that in the judgment of the investigators would interfere with the patient’s ability to provide informed consent, comply with study instructions, place the patient at increased risk, or which might confound interpretation of study results.

研究者

发起方
Auto Tissue Berlin GmbH

相似试验